Stroke, Vol 25, 2215-2219, Copyright © 1994 by American Heart Association
L Hantson, W De Weerdt, J De Keyser, HC Diener, C Franke, R Palm, M Van Orshoven, H Schoonderwalt, N De Klippel and L Herroelen
BACKGROUND AND PURPOSE: For detecting therapeutic effect and matching of
treatment groups in stroke trials, a scale that meets the clinimetric
criteria is of the utmost importance. METHODS: The European Stroke Scale
consists of 14 items selected for their specificity and their prognostic
value. It is designed for patients with middle cerebral artery stroke.
Interrater reliability, internal consistency, and time for completion were
investigated in 74 patients. Intrarater reliability was studied in 38
patients. To establish concurrent validity, two trials were performed in 20
and 44 patients. The scale was correlated with the MCA Neurological Scale,
the Canadian Stroke Scale, the Scandinavian Stroke Scale, the Barthel
Index, and the Rankin Scale. Correlations were calculated by means of
Spearman's correlation coefficient. The trial in 44 patients also
investigated the prognostic validity of the scale for 1-month and 8-month
neurological, functional, and handicap status. These data were analyzed by
linear regression. RESULTS: Interrater (kappa value range, 0.62 to 0.85)
and intrarater (kappa value range, 0.65 to 1.00) reliability for each item
was good, and internal consistency was excellent (Cronbach's alpha
coefficient, 0.92). Mean time for completion was 8.2 minutes (range, 4 to
14 minutes). Correlations of the European Stroke Scale with other
neurological scales ranged from 0.93 to 0.95. The correlation with the
Barthel Index and the Rankin Scale was 0.84 and -0.86. The R2 values for
prognostic validity ranged from 0.45 to 0.81 (P < or = .0001).
CONCLUSIONS: The European Stroke Scale has been developed according to the
clinimetric criteria.
ARTICLES
The European Stroke Scale
FLOK, Laboratory of Neuromotor Rehabilitation, Katholieke Universiteit leuven, Belgium.
This article has been cited by other articles:
 |
|
 |
|
  M. Caimmi, S. Carda, C. Giovanzana, E. S. Maini, A. M. Sabatini, N. Smania, and F. Molteni Using Kinematic Analysis to Evaluate Constraint-Induced Movement Therapy in Chronic Stroke Patients Neurorehabil Neural Repair, February 1, 2008; 22(1): 31 - 39. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Prosser, L. MacGregor, K. R. Lees, H.-C. Diener, W. Hacke, S. Davis, and on behalf of the VISTA Investigators Predictors of Early Cardiac Morbidity and Mortality After Ischemic Stroke Stroke, August 1, 2007; 38(8): 2295 - 2302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Banks and C. A. Marotta Outcomes Validity and Reliability of the Modified Rankin Scale: Implications for Stroke Clinical Trials: A Literature Review and Synthesis Stroke, March 1, 2007; 38(3): 1091 - 1096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Weller, H.-J. Wittsack, M. Siebler, V. Homberg, and R. J. Seitz Motor Recovery as Assessed with Isometric Finger Movements and Perfusion Magnetic Resonance Imaging after Acute Ischemic Stroke Neurorehabil Neural Repair, September 1, 2006; 20(3): 390 - 397. [Abstract] [PDF]
|
|
|
|
 |
|
 W.-C. Shyu, S.-Z. Lin, C.-C. Lee, D. D. Liu, and H. Li Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial Can. Med. Assoc. J., March 28, 2006; 174(7): 927 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Seitz, S. Meisel, P. Weller, U. Junghans, H.-J. Wittsack, and M. Siebler Initial Ischemic Event: Perfusion-weighted MR Imaging and Apparent Diffusion Coefficient for Stroke Evolution Radiology, December 1, 2005; 237(3): 1020 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Seitz, S. Meisel, M. Moll, H. -J. Wittsack, U. Junghans, and M. Siebler The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions Neurology, June 8, 2004; 62(11): 2110 - 2112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Sachdev, H. Brodaty, M. J. Valenzuela, L. Lorentz, J. C.L. Looi, W. Wen, and A. S. Zagami The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients Neurology, March 23, 2004; 62(6): 912 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Verheyden, A Nieuwboer, J Mertin, R Preger, C Kiekens, and W De Weerdt The Trunk Impairment Scale: a new tool to measure motor impairment of the trunk after stroke Clinical Rehabilitation, March 1, 2004; 18(3): 326 - 334. [Abstract] [PDF]
|
|
|
|
|
|
J.M. Wardlaw, S.L. Keir, M.E. Bastin, P.A. Armitage, and A.K. Rana Is diffusion imaging appearance an independent predictor of outcome after ischemic stroke? Neurology, November 12, 2002; 59(9): 1381 - 1387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Steinke and S. C. Ley Lacunar Stroke Is the Major Cause of Progressive Motor Deficits Stroke, June 1, 2002; 33(6): 1510 - 1516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Gotoh, Y. Terayama, and T. Amano Development of a Novel, Weighted, Quantifiable Stroke Scale: Japan Stroke Scale Stroke, August 1, 2001; 32(8): 1800 - 1807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Diener, E. B. Ringelstein, R. von Kummer, H. D. Langohr, H. Bewermeyer, H. Landgraf, M. Hennerici, D. Welzel, M. Grave, J. Brom, et al. Treatment of Acute Ischemic Stroke With the Low-Molecular-Weight Heparin Certoparin : Results of the TOPAS Trial Stroke, January 1, 2001; 32(1): 22 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Federlein, T. Postert, S Meves, S Weber, H Przuntek, and T. Buttner Ultrasonic evaluation of pathological brain perfusion in acute stroke using second harmonic imaging J. Neurol. Neurosurg. Psychiatry, November 1, 2000; 69(5): 616 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Diener, M. Cortens, G. Ford, J. Grotta, W. Hacke, M. Kaste, P. J. Koudstaal, and T. Wessel Lubeluzole in Acute Ischemic Stroke Treatment : A Double-Blind Study With an 8-Hour Inclusion Window Comparing a 10-mg Daily Dose of Lubeluzole With Placebo Stroke, November 1, 2000; 31(11): 2543 - 2551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kondziolka, L. Wechsler, S. Goldstein, C. Meltzer, K. R. Thulborn, J. Gebel, P. Jannetta, S. DeCesare, E. M. Elder, M. McGrogan, et al. Transplantation of cultured human neuronal cells for patients with stroke Neurology, August 22, 2000; 55(4): 565 - 569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M Pomeroy, C. Frames, E. B Faragher, A. Hesketh, E. Hill, P. Watson, and C. J Main Reliability of a measure of post-stroke shoulder pain in patients with and without aphasia and/or unilateral spatial neglect Clinical Rehabilitation, June 1, 2000; 14(6): 584 - 591. [Abstract] [PDF]
|
|
|
|
|
|
P. W. Duncan, H. S. Jorgensen, and D. T. Wade Outcome Measures in Acute Stroke Trials : A Systematic Review and Some Recommendations to Improve Practice Stroke, June 1, 2000; 31(6): 1429 - 1438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Chatterton, V. M. Pomeroy, M. J. Connolly, E. B. Faragher, L. Clayton, and R. C. Tallis The Effect of Body Position on Arterial Oxygen Saturation in Acute Stroke J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2000; 55(4): 239M - 244. [Abstract] [Full Text]
|
|
|
|
|
|
P. Wester, J. Radberg, B. Lundgren, and M. Peltonen Factors Associated With Delayed Admission to Hospital and In-Hospital Delays> in Acute Stroke and TIA : A Prospective, Multicenter Study Stroke, January 1, 1999; 30(1): 40 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. del Zoppo, R. T. Higashida, A. J. Furlan, M. S. Pessin, H. A. Rowley, and M. Gent PROACT: A Phase II Randomized Trial of Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute Middle Cerebral Artery Stroke Stroke, January 1, 1998; 29(1): 4 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Goldstein and V. Chilukuri Retrospective Assessment of Initial Stroke Severity With the Canadian Neurological Scale Stroke, June 1, 1997; 28(6): 1181 - 1184. [Abstract] [Full Text]
|
|
|
|
|
|
L. D'Olhaberriague, I. Litvan, P. Mitsias, and H. H. Mansbach A Reappraisal of Reliability and Validity Studies in Stroke Stroke, December 1, 1996; 27(12): 2331 - 2336. [Abstract] [Full Text]
|
|
|
|
|
|
K. W. Muir, C. J. Weir, G. D. Murray, C. Povey, and K. R. Lees Comparison of Neurological Scales and Scoring Systems for Acute Stroke Prognosis Stroke, October 1, 1996; 27(10): 1817 - 1820. [Abstract] [Full Text]
|
|
|
|
|
|
H.C. Diener, W. Hacke, M. Hennerici, J. Radberg, L. Hantson, and J. De Keyser Lubeluzole in Acute Ischemic Stroke : A Double-blind, Placebo-Controlled Phase II Trial Stroke, January 1, 1996; 27(1): 76 - 81. [Abstract] [Full Text]
|
|
|
|
|
|
J.V. Bowler, J.P.H. Wade, B.E. Jones, K. Nijran, and T.J. Steiner Single-Photon Emission Computed Tomography Using Hexamethylpropyleneamine Oxime in the Prognosis of Acute Cerebral Infarction Stroke, January 1, 1996; 27(1): 82 - 86. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. J. del Zoppo Acute Stroke -- On the Threshold of a Therapy? N. Engl. J. Med., December 14, 1995; 333(24): 1632 - 1633. [Full Text]
|
|
|
|
|
|
D. F. Edwards, Y.-W. Chen MSW, and M. N. Diringer Unified Neurological Stroke Scale Is Valid in Ischemic and Hemorrhagic Stroke Stroke, October 1, 1995; 26(10): 1852 - 1858. [Abstract] [Full Text]
|
|